ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.04.03.535346
Publication URI: http://dx.doi.org/10.1101/2023.04.03.535346
Type: Preprint